Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$32.1M Buy
510,269
+205,224
+67% +$14.4M 0.01% 982
2026
Q1
$23M Buy
305,045
+56,952
+23% +$4.06M 0.01% 985
2025
Q4
$15.3M Buy
248,093
+229,549
+1,238% +$13.5M 0.01% 1033
2025
Q3
$1.09M Buy
18,544
+12,280
+196% +$716K ﹤0.01% 2384
2025
Q2
$365K Buy
+6,264
New +$354K ﹤0.01% 2766
2024
Q3
Sell
-5,348
Closed -$272K 2842
2024
Q2
$272K Buy
5,348
+1,184
+28% +$64.8K ﹤0.01% 2309
2024
Q1
$226K Buy
+4,164
New +$217K ﹤0.01% 2229
2019
Q2
Sell
-44,678
Closed -$2.36M 2144
2019
Q1
$2.36M Sell
44,678
-144
-0.3% -$7.5K ﹤0.01% 1254
2018
Q4
$2.1M Buy
44,822
+2,746
+7% +$143K ﹤0.01% 1231
2018
Q3
$2.43M Buy
42,076
+10,040
+31% +$556K ﹤0.01% 1323
2018
Q2
$1.74M Buy
+32,036
New +$1.59M ﹤0.01% 1486

Other funds holding NTR

Cliff Asness's NTR Position: Q2 2026 in Review

Cliff Asness increased its Nutrien (NTR) stake by 67% in Q2 2026, buying an estimated $14.4M and bringing the position to 510,269 shares worth $32.1M. The position accounts for 0.01% of the portfolio, ranked #982.

Cliff Asness first reported a position in NTR in Q2 2018 and has held it in 11 quarters since. 728 funds tracked by Wall St. Rank hold NTR as of Q2 2026.

  • Cliff Asness held 510,269 shares of Nutrien worth $32.1M as of Q2 2026.
  • Cliff Asness bought 205,224 Nutrien shares in Q2 2026, an estimated $14.4M.
  • Nutrien made up 0.01% of Cliff Asness's portfolio in Q2 2026, its #982 holding.
  • Cliff Asness first reported a position in Nutrien in Q2 2018 and has held it in 11 quarters since.
  • 728 funds tracked by Wall St. Rank held Nutrien as of Q2 2026.

Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.